According to the New England Journal of Medicine phase 2 clinical trial involving 338 adults, retatrutide showed significant weight loss, which was mainly dose-dependent
Available from: Madsen LW, Knauf JA, Gotfredsen C, Pilling A, Sjgren I, Andersen S, et al
You can read more about TB-500's research background and current regulatory status in our TB-500 tissue repair research overview
For many biotech companies, scaling is generally easier in North Carolina thanks to available land, zoning flexibility, and workforce depth beyond the Triangle
Be sure to talk to your healthcare provider before starting these medications if you have depression, other mental illness, diabetes, or are 65 years or older
What matters is the weekly cadence and the consistency of your overall protocol not whether you injected at 8 AM versus 11 AM on any single week